PATENT CLAIM ANALYSIS

Application Number: 15910661
Application Type: Utility
Filing Date: 2018-03
Publication Date: 2018-08
Patent Classification: ["514", "167000"]

Abstract:
This invention relates to methods for improving the quality of the meibum composition of the meibomian glands to enhance or improve the lipid layer of the tear and increase tear breakup time by way of elevating the omega-3 index in patients suffering from symptoms of dry eye, posterior blepharitis, and/or meibomian gland dysfunction. The methods comprise administering a supplementation of omega-3 fatty acids to a patient having an inflamed meibomian gland so as to facilitate an increase in the amount of omega-3's acting as an anti-inflammatory and, respectively, decrease the amount of omega-6's (arachidonic acid) acting as an inflammatory in the composition of the meibum, thereby normalizing the lipid layer of the tear and effectively reducing the associated symptoms. In certain embodiments, the supplementation of omega-3's comprises the esterified or re-esterified triglyceride form.

Claim (Index 5):
The composition as defined in  claim 1 , wherein said omega-3 fatty acids comprise an effective amount of EPA and an effective amount of DHA, wherein comprising a 3:1 ratio of EPA to DHA.

Metadata:
- Claim Count in Document: 52.0
- Percentile: 90.0
- Lexical Diversity: 1.79268
- Patent Class: 514.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['13815599', '13507673', '10521067', '15555527', '14427927']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7617334686650868
- 35 USC 102 Novelty (BERT): 0.6220197400292802
- Combined Prediction Score: 0.7477620958015062
- Mean Citation Score: 384.22435600000006
- Max Citation Score: 616.5456
- Similarity Product: 502.96618443431856

Labels:
- Claim Label 101: 1
- Claim Label 102: 0
- Claim Label 103: 1
- Claim Label 112: 0
- Combined Label: 0
- Label 101 Adjusted: 1

Dataset: test